223 related articles for article (PubMed ID: 35818125)
1. Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting.
Cao P; Smith L; Mandelblatt JS; Jeon J; Taylor KL; Zhao A; Levy DT; Williams RM; Meza R; Jayasekera J
JNCI Cancer Spectr; 2022 Jul; 6(4):. PubMed ID: 35818125
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study.
Cadham CJ; Cao P; Jayasekera J; Taylor KL; Levy DT; Jeon J; Elkin EB; Foley KL; Joseph A; Kong CY; Minnix JA; Rigotti NA; Toll BA; Zeliadt SB; Meza R; Mandelblatt J;
J Natl Cancer Inst; 2021 Aug; 113(8):1065-1073. PubMed ID: 33484569
[TBL] [Abstract][Full Text] [Related]
4. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
5. Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.
Taylor KL; Deros DE; Fallon S; Stephens J; Kim E; Lobo T; Davis KM; Luta G; Jayasekera J; Meza R; Stanton CA; Niaura RS; Abrams DB; McKee B; Howell J; Ramsaier M; Batlle J; Dornelas E; Parikh V; Anderson E
Contemp Clin Trials; 2019 Jul; 82():25-35. PubMed ID: 31129371
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting.
Taylor KL; Williams RM; Li T; Luta G; Smith L; Davis KM; Stanton CA; Niaura R; Abrams D; Lobo T; Mandelblatt J; Jayasekera J; Meza R; Jeon J; Cao P; Anderson ED;
J Natl Cancer Inst; 2022 Oct; 114(10):1410-1419. PubMed ID: 35818122
[TBL] [Abstract][Full Text] [Related]
7. Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial.
Cummins S; Zhu SH; Gamst A; Kirby C; Brandstein K; Klonoff-Cohen H; Chaplin E; Morris T; Seymann G; Lee J
Trials; 2012 Aug; 13():128. PubMed ID: 22853197
[TBL] [Abstract][Full Text] [Related]
8. Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.
Taylor KL; Hagerman CJ; Luta G; Bellini PG; Stanton C; Abrams DB; Kramer JA; Anderson E; Regis S; McKee A; McKee B; Niaura R; Harper H; Ramsaier M
Lung Cancer; 2017 Jun; 108():242-246. PubMed ID: 28216065
[TBL] [Abstract][Full Text] [Related]
9. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.
Berndt N; Bolman C; Lechner L; Max W; Mudde A; de Vries H; Evers S
Eur J Health Econ; 2016 Apr; 17(3):269-85. PubMed ID: 25796578
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
[TBL] [Abstract][Full Text] [Related]
12. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
13. Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: A model-based cost-effectiveness analysis.
Diaz M; Garcia M; Vidal C; Santiago A; Gnutti G; Gómez D; Trapero-Bertran M; Fu M;
Lung Cancer; 2021 Sep; 159():153-161. PubMed ID: 34352591
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
[TBL] [Abstract][Full Text] [Related]
15. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
[TBL] [Abstract][Full Text] [Related]
16. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Keating GM; Lyseng-Williamson KA
Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model.
Park SK; Kang DW; Lee EK
Nicotine Tob Res; 2022 Nov; 24(12):2011-2017. PubMed ID: 35862219
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of population-level proactive tobacco cessation outreach among socio-economically disadvantaged smokers: evaluation of a randomized control trial.
Thao V; Nyman JA; Nelson DB; Joseph AM; Clothier B; Hammett PJ; Fu SS
Addiction; 2019 Dec; 114(12):2206-2216. PubMed ID: 31483549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
